These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

857 related items for PubMed ID: 25495136

  • 1. Risk of recurrent venous thromboembolism among deep vein thrombosis and pulmonary embolism patients treated with warfarin.
    Nordstrom BL, Evans MA, Murphy BR, Nutescu EA, Schein JR, Bookhart BK.
    Curr Med Res Opin; 2015 Mar; 31(3):439-47. PubMed ID: 25495136
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI, Bunz TJ, Turpie AGG.
    Thromb Haemost; 2017 Oct 05; 117(10):1841-1847. PubMed ID: 28640322
    [Abstract] [Full Text] [Related]

  • 4. Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting.
    Willey VJ, Bullano MF, Hauch O, Reynolds M, Wygant G, Hoffman L, Mayzell G, Spyropoulos AC.
    Clin Ther; 2004 Jul 05; 26(7):1149-59. PubMed ID: 15336480
    [Abstract] [Full Text] [Related]

  • 5. Effectiveness and safety of rivaroxaban and warfarin in patients with unprovoked venous thromboembolism: a propensity-matched nationwide cohort study.
    Larsen TB, Skjøth F, Kjældgaard JN, Lip GYH, Nielsen PB, Søgaard M.
    Lancet Haematol; 2017 May 05; 4(5):e237-e244. PubMed ID: 28411120
    [Abstract] [Full Text] [Related]

  • 6. Tinzaparin vs Warfarin for Treatment of Acute Venous Thromboembolism in Patients With Active Cancer: A Randomized Clinical Trial.
    Lee AYY, Kamphuisen PW, Meyer G, Bauersachs R, Janas MS, Jarner MF, Khorana AA, CATCH Investigators.
    JAMA; 2015 Aug 18; 314(7):677-686. PubMed ID: 26284719
    [Abstract] [Full Text] [Related]

  • 7. Effect of Low-Intensity vs Standard-Intensity Warfarin Prophylaxis on Venous Thromboembolism or Death Among Patients Undergoing Hip or Knee Arthroplasty: A Randomized Clinical Trial.
    Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Anderson JL, Li J, Rodriguez T, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, Whipple B, Porche-Sorbet R, Napoli L, Merritt K, Thompson AM, Hyun G, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Dávila-Román V, Eby CS.
    JAMA; 2019 Sep 03; 322(9):834-842. PubMed ID: 31479138
    [Abstract] [Full Text] [Related]

  • 8. Warfarin Discontinuation in Patients With Unprovoked Venous Thromboembolism: A Large US Insurance Database Analysis.
    Xie L, Liu X, Phatak H, Mardekian J, Tan W, Baser O, Ramacciotti E.
    Am J Ther; 2016 Sep 03; 23(6):e1744-e1753. PubMed ID: 26214203
    [Abstract] [Full Text] [Related]

  • 9. Warfarin initiation nomograms for venous thromboembolism.
    Garcia P, Ruiz W, Loza Munárriz C.
    Cochrane Database Syst Rev; 2016 Jan 29; 2016(1):CD007699. PubMed ID: 26822633
    [Abstract] [Full Text] [Related]

  • 10. Bleeding complications and mortality in warfarin-treated VTE patients, dependence of INR variability and iTTR.
    Sandén P, Renlund H, Svensson PJ, Själander A.
    Thromb Haemost; 2017 Jan 05; 117(1):27-32. PubMed ID: 27652593
    [Abstract] [Full Text] [Related]

  • 11. Changing Treatment Patterns in Patients With Venous Thromboembolism in Taiwan.
    Lee CH, Fang CC, Tsai LM, Lin HW, Chen PS, Lin SH, Li YH.
    Circ J; 2020 Jan 24; 84(2):283-293. PubMed ID: 31932560
    [Abstract] [Full Text] [Related]

  • 12. One-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent events.
    Chen SY, Wu N, Gulseth M, LaMori J, Bookhart BK, Boulanger L, Fields L, Schein J.
    J Manag Care Pharm; 2013 May 24; 19(4):291-301. PubMed ID: 23627575
    [Abstract] [Full Text] [Related]

  • 13. Warfarin initiation nomograms for venous thromboembolism.
    Garcia P, Ruiz W, Loza Munarriz C.
    Cochrane Database Syst Rev; 2013 Jul 10; (7):CD007699. PubMed ID: 23839808
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A re-appraisal of warfarin control in the treatment of deep vein thrombosis and / or pulmonary embolism.
    Amiwero C, Campbell IA, Prescott RJ.
    Afr Health Sci; 2009 Sep 10; 9(3):179-85. PubMed ID: 20589148
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
    Caprini JA, Tapson VF, Hyers TM, Waldo AL, Wittkowsky AK, Friedman R, Colgan KJ, Shillington AC, NABOR Steering Committee.
    J Vasc Surg; 2005 Oct 10; 42(4):726-33. PubMed ID: 16242561
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The study of Chinese optimal anticoagulant range of warfarin for venous thromboembolism].
    Yang P, Wu QH, Luo XY, Kou L, Chen Z, Zhang YY, Zhou H.
    Zhonghua Yi Xue Za Zhi; 2009 Jul 07; 89(25):1762-5. PubMed ID: 19862981
    [Abstract] [Full Text] [Related]

  • 20. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism.
    Ridker PM, Goldhaber SZ, Danielson E, Rosenberg Y, Eby CS, Deitcher SR, Cushman M, Moll S, Kessler CM, Elliott CG, Paulson R, Wong T, Bauer KA, Schwartz BA, Miletich JP, Bounameaux H, Glynn RJ, PREVENT Investigators.
    N Engl J Med; 2003 Apr 10; 348(15):1425-34. PubMed ID: 12601075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.